By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


GI Dynamics 

Boston  Massachusetts    U.S.A.
Phone: 617-454-6025 Fax:


Medical Device

Company News
New GI Dynamics (GID.AX) CEO Schorer Looks To Reboot EndoBarrier 5/25/2016 7:52:46 AM
GI Dynamics (GID.AX) Appoints Chief Compliance Officer 5/10/2016 12:54:35 PM
GI Dynamics (GID.AX) Releases Safety And Efficacy Data For Endobarrier Therapy 5/9/2016 11:00:54 AM
GI Dynamics (GID.AX) Appoints Chief Financial Officer 5/6/2016 9:41:22 AM
GI Dynamics (GID.AX) Appoints Medtech Vet Scott Schorer as President & CEO 3/23/2016 10:39:30 AM
German Diabetes Society Releases Statement Regarding GI Dynamics (GID.AX)’ Termination of U.S. ENDO Trial 9/28/2015 1:28:59 PM
GI Dynamics (GID.AX) Axes Workforce by 46% 8/21/2015 7:05:18 AM
GI Dynamics (GID.AX): Appendix 4C Quarterly Report Quarter Ended 30 June 2015 7/30/2015 1:34:42 PM
GI Dynamics (GID.AX) Discontinues U.S. Trial of EndoBarrier Therapy 7/30/2015 7:56:21 AM
GI Dynamics (GID.AX) Release: New Data Presented At American Diabetes Association Demonstrate Early Effect Of Endobarrier Therapy On Glucose Control And Bile Acid Regulators 6/8/2015 11:28:39 AM